Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial
British medical journal February 2, 2022 M. Abbar, C. Demattei, Wissam El-Hage et al. 172 citations
Abstract Objective To confirm the rapid onset anti-suicidal benefits of ketamine in the short term and at six weeks, overall and according to diagnostic group. Design Prospective, double blind, superiority, randomised placebo controlled trial. Setting Seven French teaching hospitals between 13 April 2015 and 12 March 2019. Eligibility criteria for participants Aged 18 or older with current...